# Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer

> **NCT06197425** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 1660 (estimated)

## Conditions studied

- Colon or Upper Rectum Adenocarcinoma

## Interventions

- **DRUG:** "FOLFIRI" cures
- **DRUG:** Trifluridine cures
- **BIOLOGICAL:** BIOLOGICAL ASSESSMENT
- **OTHER:** Questionnaires
- **OTHER:** Thoracic-abdomino-pelvic scan or MRI

## Key facts

- **NCT ID:** NCT06197425
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 1660 (ESTIMATED)
- **Last updated:** 2024-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06197425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06197425, "Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06197425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*